All publications of “Patrícia Weinschenker Bollmann”

4 results

Multiple myeloma complicated with pseudomonas endocartiditis

Juliana Todaro, Patrícia Weinschenker Bollmann, Amit Nussbacher, Luis Fernando Aranha Camargo, Bento Fortunato Cardoso dos Santos, Daniel Alvarenga, [...]

DOI: 10.1590/S1679-45082012000400017

Patients diagnosed with multiple myeloma are more susceptible to infections which are the major causes of morbidity and mortality associated to this disease. The main infectious agents involved are Gram-positive bacteria. However, after chemotherapy an increase in the incidence of Gram-negative strains is observed. These bacteria are also responsible for most cases of urinary tract infections. Here is reported a rare case in a 73-year-old man with multiple myeloma who developed endocarditis due to pseudomonas.

Hodgkin’s disease and pregnancy: case series and proposal for treatment protocol

Carolina Kassab, Guilherme Fleury Perini, Patrícia Weinschenker Bollmann, Fabio Rodrigues Kerbauy, Nelson Hamerschlak

DOI: 10.1590/S1679-45082011RC1992

ABSTRACT The peak frequency of Hodgkin’s disease convergesmatches with women of reproductive fertility age. Currently, this disease is the fourth more diagnosed neoplasia during pregnancy. In addition, there is no consensus in the literature on how to treat pregnant women because of the risks of chemotherapy for mothers and for fetuses. We report three cases of pregnant women with Hodgkin’s disease. A review of the literature was made aiming to suggest a protocol to treat these patients.

Chronic myeloid leukemia: past, present, future

Patricia Weinschenker Bollmann, Auro del Giglio

DOI: 10.1590/S1679-45082011RB2022

ABSTRACT The discovery of the Philadelphia chromosome in 1960, and of the BCR-ABL oncogene in 1984, enabled the development in subsequent years of a targeted therapy that revolutionized the treatment of chronic myeloid leukemia, thus changing its natural history. The use of imatinib resulted in a significant improvement of the prognosis and outcome of patients with chronic myeloid leukemia. However, the occurrence of mechanisms of resistance or intolerance precludes the eradication of the disease in some of the patients. Second-generation […]

Livedoid vasculopathy: fast involution after anticoagulant and hyperbaric oxygen therapy

Patricia Weinschenker Bollmann, Andréa Kazumi Shimada, Nilceo Schwery Michalany, Ana Rita de Araújo Burgos Manhani, Auro del Giglio

DOI: 10.1590/S1679-45082011RC1676

ABSTRACT The livedoid vasculopathy is a rare condition characterized by the presence of recurrent painful ulcers in distal extremities of lower limbs. Histologically there is thickness of dermal vessels, occlusion of its light by fibrin thrombi associated with minimal inflammatory infiltrate. It might occur as an isolated condition or be associated with an underlying systemic disease, including coagulation and collagen disorders, or neoplasms. Because it is a rare disease there is no consensus for its treatment. We report a case […]